Truist Securities Reiterates Hold on Teladoc Health, Maintains $28 Price Target
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Jailendra Singh has reiterated a 'Hold' rating on Teladoc Health (NYSE:TDOC) and maintained a price target of $28.
September 25, 2023 | 12:32 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Truist Securities has reiterated a 'Hold' rating on Teladoc Health, maintaining a price target of $28.
The news directly pertains to Teladoc Health as Truist Securities has reiterated their 'Hold' rating on the company. This suggests that the analyst believes the stock is fairly valued at its current price, indicating a neutral short-term impact. The maintained price target of $28 also suggests no significant changes in the company's valuation.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100